Beyond the great content, the network and relationships built over the five intensive days were invaluable.
I joined the IBE 2025 program in Leiden to expand my understanding of biomedical startups, their investment landscape, and the unique challenges of this sector. The program not only delivered insights into these areas but far exceeded expectations in both scope and impact.
Curtis brought his signature energy, passion, and vision to every aspect of the program. He curated a unique lineup of speakers — investors, entrepreneurs, legal and regulatory experts, and industry leaders — each offering valuable perspectives through engaging, thought-provoking sessions.
One of the most refreshing aspects for me was the exposure to the American mindset and the interplay between the US market and investors with European startups, and vice versa.
Beyond the great content, the network and relationships built over the five intensive days were invaluable. Curtis fostered an environment that encouraged openness, collaboration, and genuine exchange, and the sessions related to the EurekaConnect program added a layer of self-discovery and personal development.
Highly recommended for anyone looking to gain a global view of the biomedical innovation ecosystem and to be inspired by leaders who truly believe in empowering others to make impact.
The IBE brings the specialized know-how and the funding required for translational development success.
The IBE is a lean operating company that uses disciplined processes, leverages existing resources (incubators, CROs), and taps into expert networks to work on many product opportunities in parallel, rather than trying to build one startup at a time.
Contact Us